This month on The BloodStream Podcast, Shire and Roche are locked up in a legal dispute related to Hemlibra, what does this mean and will it impact patients’ ability to receive Hemlibra? We discuss in today’s Comment Segment. A New York Times article examines why the United States spends so much more money on healthcare than any other country in a story presented by Natalie in our Like Segment, and entrepreneur and hemo dad Mark Kenny shares his compelling story and perspective during our Share Segment. Plus Natalie and I sit down with hemo mom (and Patrick’s mom!) Susan Lynch to get her perspective of being introduced to hemophilia in the mid-1980’s and how she navigated being a single parent of two kids with hemophilia during the advent of recombinant products and prophylaxis. All that and more on this Episode 20 of The BloodStream Podcast!
Exclusive Sponsor: Shire
Share Segment: Mark Kenny: Entrepreneur and Hemo Dad
Comment Segment: Shire and Roche locked in legal dispute over Hemlibra.
From Biopharma Dive, “Shire looks to stall Hemlibra impact with court injunction”
Other Links of Interest
Connect with BloodStream:
Find all of our bleeding disorders podcasts on BloodStreamMedia.com
Subscribe to BloodStream:
Google Play: http://bit.ly/bloodstreamPlay